1-9 of 9
Vinod Pullarkat
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy

Clinical Trials & Observations
Geoffrey L. Uy, Vinod Pullarkat, Praneeth Baratam, Robert K. Stuart, Roland B. Walter, Eric S. Winer, Qi Wang, Stefan Faderl, Divya Chakravarthy, Diane Menno, Ronald S. Cheung, Tara L. Lin
Journal: Blood Advances
Blood Adv (2024) 8 (24): 6248–6256.
https://doi.org/10.1182/bloodadvances.2024013687
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL

Clinical Trials & Observations
Ibrahim Aldoss, Gregory W. Roloff, Rawan Faramand, Noam E. Kopmar, Chenyu Lin, Anjali S. Advani, Simone E. Dekker, Vishal K. Gupta, Timothy E. O'Connor, Nikeshan Jeyakumar, Ibrahim N. Muhsen, Yannis Valtis, Amy Zhang, Katharine Miller, Katherine Sutherland, Kaitlyn C. Dykes, Mohamed Ahmed, Evan Chen, Hector Zambrano, Danielle Bradshaw, Santiago Mercadal, Marc Schwartz, Sean Tracy, Bhagirathbhai Dholaria, Michal Kubiak, Akash Mukherjee, Navneet Majhail, Minoo Battiwalla, Luke Mountjoy, Shahbaz A. Malik, John Mathews, Paul Shaughnessy, Aaron C. Logan, Abdullah Ladha, Maryann Stefan, Caitlin Guzowski, Rasmus T. Hoeg, Talal Hilal, Jozal Moore, Matthew Connor, Kristen M. O'Dwyer, LaQuisa C. Hill, Stephanie B. Tsai, Joshua Sasine, Melhem M. Solh, Catherine J. Lee, Vamsi K. Kota, Divya Koura, Muthu Veeraputhiran, Betsy Blunk, Caspian Oliai, Jessica T. Leonard, Noelle V. Frey, Jae H. Park, Marlise R. Luskin, Veronika Bachanova, Ahmed Galal, Michael R. Bishop, Wendy Stock, Ryan D. Cassaday, Vinod Pullarkat, Bijal D. Shah, Lori S. Muffly
Journal: Blood Advances
Blood Adv (2024) 8 (23): 6139–6147.
https://doi.org/10.1182/bloodadvances.2024013747
Published: 2024
Includes: Supplemental data
Journal Articles

Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1 -mutant AML

Jan Philipp Bewersdorf, Shai Shimony, Rory M. Shallis, Yiwen Liu, Guillaume Berton, Eva J. Schaefer, Amer M. Zeidan, Aaron D. Goldberg, Eytan M. Stein, Guido Marcucci, Rebecca P. Bystrom, R. Coleman Lindsley, Evan C. Chen, Jorge Ramos Perez, Anthony Stein, Vinod Pullarkat, Ibrahim Aldoss, Daniel J. DeAngelo, Donna S. Neuberg, Richard M. Stone, Sylvain Garciaz, Brian Ball, Maximilian Stahl
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4845–4855.
https://doi.org/10.1182/bloodadvances.2024012858
Published: 2024
Includes: Supplemental data
Journal Articles

Interferon-γ blockade in CAR T-cell therapy–associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis

Clinical Trials & Observations
Michael Rainone, Dat Ngo, John H. Baird, L. Elizabeth Budde, Myo Htut, Ibrahim Aldoss, Vinod Pullarkat
Journal: Blood Advances
Blood Adv (2023) 7 (4): 533–536.
https://doi.org/10.1182/bloodadvances.2022008256
Published: 2023
Journal Articles

Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL

Ibrahim Aldoss, Dongyun Yang, Vanina Tomasian, Sally Mokhtari, Ryan Jackson, Zhaohui Gu, Milhan Telatar, Hooi Yew, Monzr M. Al Malki, Amandeep Salhotra, Samer Khaled, Haris Ali, Ahmed Aribi, Karamjeet S. Sandhu, Matthew Mei, Shukaib Arslan, Paul Koller, Andrew Artz, Patricia Aoun, Dongqing Gu, David Snyder, Forrest M. Stewart, Peter Curtin, Anthony S. Stein, Raju Pillai, Guido Marcucci, Stephen J. Forman, Vinod Pullarkat, Ryotaro Nakamura, Michelle Afkhami
Journal: Blood Advances
Blood Adv (2022) 6 (17): 4936–4948.
https://doi.org/10.1182/bloodadvances.2022007597
Published: 2022
Includes: Supplemental data
Journal Articles

Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study

Clinical Trials & Observations
Haris Ali, Ni-Chun Tsai, Timothy Synold, Sally Mokhtari, Weimin Tsia, Joycelynne Palmer, Tracey Stiller, Monzr Al Malki, Ibrahim Aldoss, Amandeep Salhotra, Syed Rahmanuddin, Vinod Pullarkat, Ji-Lian Cai, Anthony Stein, Stephen J. Forman, Guido Marcucci, Matthew Mei, David S. Snyder, Ryotaro Nakamura
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1444–1453.
https://doi.org/10.1182/bloodadvances.2021005035
Published: 2022
Includes: Supplemental data
Journal Articles

Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)

Se young Han, Krzysztof Mrózek, Jenna Voutsinas, Qian Wu, Elizabeth A. Morgan, Hanne Vestergaard, Robert Ohgami, Philip M. Kluin, Thomas Kielsgaard Kristensen, Sheeja Pullarkat, Michael Boe Møller, Ana-Iris Schiefer, Linda B. Baughn, Young Kim, David Czuchlewski, Jacobien R. Hilberink, Hans-Peter Horny, Tracy I. George, Michelle Dolan, Nam K. Ku, Cecilia Arana Yi, Vinod Pullarkat, Jessica Kohlschmidt, Amandeep Salhotra, Lori Soma, Clara D. Bloomfield, Dong Chen, Wolfgang R. Sperr, Guido Marcucci, Christina Cho, Cem Akin, Jason Gotlib, Sigurd Broesby-Olsen, Melissa Larson, Michael A. Linden, H. Joachim Deeg, Gregor Hoermann, Miguel-Angel Perales, Jason L. Hornick, Mark R. Litzow, Ryotaro Nakamura, Daniel Weisdorf, Gautam Borthakur, Gerwin Huls, Peter Valent, Celalettin Ustun, Cecilia C. S. Yeung
Journal: Blood Advances
Blood Adv (2021) 5 (10): 2481–2489.
https://doi.org/10.1182/bloodadvances.2020003605
Published: 2021
Includes: Supplemental data
Journal Articles

Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents

Clinical Trials & Observations
Ibrahim Aldoss, Sanjeet Dadwal, Jianying Zhang, Bernard Tegtmeier, Matthew Mei, Shukaib Arslan, Monzr M. Al Malki, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Karamjeet Sandhu, Samer Khaled, David Snyder, Ryotaro Nakamura, Anthony S. Stein, Stephen J. Forman, Guido Marcucci, Vinod Pullarkat
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4043–4049.
https://doi.org/10.1182/bloodadvances.2019000930
Published: 2019
Journal Articles

MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen

Clinical Trials & Observations
Haris Ali, Ibrahim Aldoss, Dongyun Yang, Sally Mokhtari, Samer Khaled, Ahmed Aribi, Michelle Afkhami, Monzr M. Al Malki, Thai Cao, Matthew Mei, Margaret O’Donnell, Amandeep Salhotra, Vinod Pullarkat, Lixin Yang, Anthony S. Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Raju Pillai, David Snyder
Journal: Blood Advances
Blood Adv (2019) 3 (1): 83–95.
https://doi.org/10.1182/bloodadvances.2018026658
Published: 2019
Includes: Supplemental data